类风湿性关节炎
医学
药品
关节炎
自身免疫性疾病
疾病
关节病
药理学
抗风湿药物
免疫学
骨关节炎
软骨
滑液
生物制剂
药物开发
滑膜
慢性病
关节软骨
临床疾病
评论文章
作者
Haoyue Jiang,Ze Sun,Xiaoya Zhao,Yang Wei,Xiaohan Ma,A. Tang,Yidan Wang,Jiang Li,Xiuli Bi,Huiyan Zhou,Zhe Yang
出处
期刊:Planta Medica
[Thieme Medical Publishers (Germany)]
日期:2025-11-04
卷期号:92 (04): 465-482
摘要
Rheumatoid arthritis is a chronic systemic autoimmune disease characterized by the accumulation of synovial fluid in joints, synovial inflammation, and cartilage damage. With the development of the disease, it may result in joint deformity, which affects the normal joint function of patients and seriously endangers people's life and health. According to statistics, the incidence of rheumatoid arthritis increases with age. However, there is currently no drug that can completely cure rheumatoid arthritis; only through certain drugs and measures can the progression of the disease be delayed. Plant-derived bioactive substances have garnered extensive research attention for their therapeutic potential in treating various diseases. Studies have shown that plant-derived bioactive substances play an important role in preventing rheumatoid arthritis. This review comprehensively and systematically evaluates plant-derived bioactive substances with anti-arthritic properties, specifically focusing on bioactive substances including flavonoids, polyphenols, terpenes, alkaloids, phenols, quinones, and phenylpropanoids, and elucidates their mechanisms of action to provide reference for the prevention and treatment of rheumatoid arthritis.
科研通智能强力驱动
Strongly Powered by AbleSci AI